Montse Vendrell
InvestorPartner at Alta Life Sciences · Partner at Asabys Partners
Greater Barcelona Metropolitan Area
About
Montse Vendrell brings a systems-level perspective—former founding CEO of Biocat and CEO of Barcelona Science Park—serving as a bridge among public research, startups, capital, biotech boards and AseBio in Spain.
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Experience
- Asabys PartnersPartnercurrent2025 — presentGreater Barcelona Metropolitan Area
- AseBio - Asociación Española de BioempresasBoard Membercurrent2025 — presentMadrid, Community of Madrid, Spain
- ONA TherapeuticsVice-Chair, Board of Directorscurrent2022 — presentBarcelona, Catalonia, Spain
- INBRAIN NeuroelectronicsDirector Board of Directorscurrent2022 — presentBarcelona, Catalonia, Spain
- PeptomycDirector Board of Directorscurrent2017 — presentBarcelona, Catalonia, Spain
- Accure TherapeuticsDirector Board of Directorscurrent2020 — presentBarcelona, Catalonia, Spain
- Oryzon Genomics SADirector Board of Directorscurrent2025 — present
- Board of Trustees, Pompeu Fabra UniversityPresidentcurrent2019 — presentBarcelona, Catalonia, Spain
- Pasqual Maragall FoundationVice Presidentcurrent2017 — presentBarcelona, Catalonia, Spain
- Aliath BioventuresPartner and co-Founder2022 — 2025Barcelona, Spain
- Alta Life SciencesPartner2016 — 2025Greater Barcelona Metropolitan Area
- BIST (The Barcelona Institute of Science and Technology)CEO2015 — 2016
- Biocat, BioRegion of CataloniaCEO2007 — 2015
- Barcelona Science ParkDirector General2014 — 2015
- Barcelona Science ParkDeputy Director1997 — 2007
- Consejo Superior de Investigaciones Científicas (CSIC)Postdoc1995 — 1997
- Hoffman-LaRoche, Roche Institute of Molecular BiologyPostdoc1992 — 1994
Education
- Universitat de BarcelonaPhD
- Singularity University, NASA Ames Research Park, Mountainview, CA, USFutureMed
- IESE Business SchoolPDG, executive management2006 — 2007
- Universitat Pompeu FabraMaster, Science Communication1996 — 1997
- Universitat de BarcelonaPhD, Biology1982 — 1987
- EsadeProyecto PROMOCIONA
- IESE Business SchoolPDG
- UPF Barcelona School of ManagementMs in Science Communication
- EsadePROMOCIONA
Skills & more
Strategic Planning6Strategy10Management9Cluster Development14Biotechnology99Technology Transfer92Entrepreneurship66Economic Development18Incubation12Molecular Biology40Commercialization10Science36
+12 more
ResearchLifesciencesR&DDrug DiscoveryGenomicsPharmaceutical IndustryLife SciencesBusiness InnovationHuman Resource DevelopmentBiochemistryBusiness StrategyResearch and Development (R&D)From Montse's professional profile.
Same school
Also attended Universitat de Barcelona88
Andrea AmadorCompliance Manager at Inveready Technology Investment GroupNelson CardonaController at Inveready Technology Investment GroupJosep Maria EcharriManaging Partner & CEO at Inveready Technology Investment GroupMar FernándezMarketing & Communications Manager at Inveready Technology Investment GroupMartina MilàAnalyst at Inveready Technology Investment GroupSara SecallGeneral Partner at Inveready Technology Investment Group
+ 82 more
Also attended IESE Business School153
Carlos ContiManaging Partner at Inveready Technology Investment GroupRobin LiInvestor at GGV CapitalDan LupuInvestor at Earlybird Venture CapitalSamuel GilCEO & General Partner at JME VenturesRiley RodgersVenture Partner at Valia VenturesPablo VenturaInvestor at Kfund
+ 147 more
Also attended Esade215
Francesco MoroPrincipal at Burda Principal InvestmentsAndrea AmadorCompliance Manager at Inveready Technology Investment GroupJosep Maria EcharriManaging Partner & CEO at Inveready Technology Investment GroupIgnacio FontsNon Executive Chairman at Inveready Technology Investment GroupRaúl GallegoGeneral Partner at Inveready Technology Investment GroupJoan MirallesHead of Administration & Valuation at Inveready Technology Investment Group
+ 209 more



























